B vitamins alleviate indices of neuropathic pain in diabetic rats

European Journal of Pharmacology

Volumn 612, Issue 1-3, 2009, Pages 41-47

  Jolivalt, Corinne G ^a   Mizisin, Leah M ^a   Nelson, Austin ^b   Cunha, Joice M ^a   Ramos, Khara M ^b   Bonke, Dieter ^c   Calcutt, Nigel A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MERCK KGAA   (Germany)

Author keywords

Allodynia; COX 2; Diabetes; Hyperalgesia; Oxidation; TNF ; Vitamin B

Indexed keywords

CYANOCOBALAMIN; CYCLOOXYGENASE 2; PYRIDOXINE; THIAMINE; TUMOR NECROSIS FACTOR ALPHA; VITAMIN B GROUP;

ADOLESCENT; ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; HYPERALGESIA; INFLAMMATION; LIPID OXIDATION; LOW DRUG DOSE; NEUROPATHIC PAIN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SENSORY NERVE CONDUCTION; SPRAGUE DAWLEY RAT;

ALDEHYDES; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; FEMALE; FORMALDEHYDE; HYPERALGESIA; MALONDIALDEHYDE; NEURAL CONDUCTION; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; TOUCH; VITAMIN B COMPLEX;

EID: 65549170718     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.04.028     Document Type: Article

References (58)

1. Abbas Z.G., and Swai A.B. Evaluation of the efficacy of thiamine and pyridoxine in the treatment of symptomatic diabetic peripheral neuropathy. East Afr. Med. J. 74 (1997) 803-808
2. Ali G., Pecoud A., Decrey H., and Verdon F. [Vitamin B 12 deficiency: early diagnosis in ambulatory care medicine]. Schweiz. Med. Wochenschr. 128 (1998) 1763-1771
3. Ang C.D., Alviar M.J., Dans A.L., Bautista-Velez G.G., Villaruz-Sulit M.V., Tan J.J., Co H.U., Bautista M.R., and Roxas A.A. Vitamin B for treating peripheral neuropathy. Cochrane Database Syst. Rev. (2008) CD004573
4. Babaei-Jadidi R., Karachalias N., Kupich C., Ahmed N., and Thornalley P.J. High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats. Diabetologia 47 (2004) 2235-2246
5. Bartoszyk G.D., and Wild A. B-vitamins potentiate the antinociceptive effect of diclofenac in carrageenin-induced hyperalgesia in the rat tail pressure test. Neurosci. Lett. 101 (1989) 95-100
6. Becker K.W., Kienecker E.W., and Dick P. A contribution to the scientific assessment of degenerative and regenerative processes of peripheral nerve fibers following axonotmesis under the systemic administration of vitamins B1, B6 and B12-light and electron microscopy findings of the saphenous nerve in the rabbit. Neurochirurgia (Stuttg.) 33 (1990) 113-121
7. Beltramo E., Berrone E., Tarallo S., and Porta M. Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta Diabetol. 45 (2008) 131-141
8. Calcutt N.A. Potential mechanisms of neuropathic pain in diabetes. Int. Rev. Neurobiol. 50 (2002) 205-228
9. Calcutt N.A. Experimental models of painful diabetic neuropathy. J. Neurol. Sci. 220 (2004) 137-139
10. Calcutt N.A., and Backonja M.M. Pathogenesis of pain in peripheral diabetic neuropathy. Curr. Diabetes Rep. 7 (2007) 429-434
11. Calcutt N.A., Li L., Yaksh T.L., and Malmberg A.B. Different effects of two aldose reductase inhibitors on nociception and prostaglandin E. Eur. J. Pharmacol. 285 (1995) 189-197
12. Calcutt N.A., Jorge M.C., Yaksh T.L., and Chaplan S.R. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain 68 (1996) 293-299
13. Cameron N.E., Jack A.M., and Cotter M.A. Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats. Free Radic. Biol. Med. 31 (2001) 125-135
14. Caram-Salas N.L., Reyes-Garcia G., Medina-Santillan R., and Granados-Soto V. Thiamine and cyanocobalamin relieve neuropathic pain in rats: synergy with dexamethasone. Pharmacology 77 (2006) 53-62
15. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53 (1994) 55-63
16. Cunha F.Q., Poole S., Lorenzetti B.B., and Ferreira S.H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br. J. Pharmacol. 107 (1992) 660-664
17. Cunha J.M., Jolivalt C.G., Ramos K.M., Gregory J.A., Calcutt N.A., and Mizisin A.P. Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors. Metabolism 57 (2008) 873-881
18. Ellis J.M., Folkers K., Minadeo M., VanBuskirk R., Xia L.J., and Tamagawa H. A deficiency of vitamin B6 is a plausible molecular basis of the retinopathy of patients with diabetes mellitus. Biochem. Biophys. Res. Commun. 179 (1991) 615-619
19. Eschalier A., Aumaitre O., Decamps A., and Dordain G. A comparison of the effects of vitamin B12 and aspirin in three experimental pain models in rats and mice. Psychopharmacology (Berl.) 81 (1983) 228-231
20. Foster T.S. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy. Diabetes Educ. 33 (2007) 111-117
21. Franca D.S., Souza A.L., Almeida K.R., Dolabella S.S., Martinelli C., and Coelho M.M. B vitamins induce an antinociceptive effect in the acetic acid and formaldehyde models of nociception in mice. Eur. J. Pharmacol. 421 (2001) 157-164
22. Freshwater J.D., Svensson C.I., Malmberg A.B., and Calcutt N.A. Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes 51 (2002) 2249-2255
23. George A., Schmidt C., Weishaupt A., Toyka K.V., and Sommer C. Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury. Exp. Neurol. 160 (1999) 124-132
24. Gorson K.C., and Ropper A.H. Additional causes for distal sensory polyneuropathy in diabetic patients. J. Neurol. Neurosurg. Psychiatry 77 (2006) 354-358
25. Hanck A., and Weiser H. Analgesic and anti-inflammatory properties of vitamins. Int. J. Vitam. Nutr. Res., Suppl. 27 (1985) 189-206
26. Haupt E., Ledermann H., and Kopcke W. Benfotiamine in the treatment of diabetic polyneuropathy-a three-week randomized, controlled pilot study (BEDIP study). Int. J. Clin. Pharmacol. Ther. 43 (2005) 71-77
27. Leuschner J. Antinociceptive properties of thiamine, pyridoxine and cyanocobalamin following repeated oral administration to mice. Arzneimittelforschung 42 (1992) 114-115
28. Malmberg A.B., and Yaksh T.L. Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J. Neurosci. 15 (1995) 2768-2776
29. Malmberg A.B., Yaksh T.L., and Calcutt N.A. Anti-nociceptive effects of the GM1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic rats. Neurosci. Lett. 161 (1993) 45-48
30. Metz T.O., Alderson N.L., Thorpe S.R., and Baynes J.W. Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications. Arch. Biochem. Biophys. 419 (2003) 41-49
31. Mixcoatl-Zecuatl T., Quinonez-Bastidas G.N., Caram-Salas N.L., Ambriz-Tututi M., Araiza-Saldana C.I., Rocha-Gonzalez H.I., Medina-Santillan R., Reyes-Garcia G., and Granados-Soto V. Synergistic antiallodynic interaction between gabapentin or carbamazepine and either benfotiamine or cyanocobalamin in neuropathic rats. Methods Find. Exp. Clin. Pharmacol. 30 (2008) 431-441
32. Nava-Ocampo A.A., Pastrak A., Cruz T., and Koren G. Pharmacokinetics of high doses of cyanocobalamin administered by intravenous injection for 26 weeks in rats. Clin. Exp. Pharmacol. Physiol. 32 (2005) 13-18
33. Okada M., Shibuya M., Yamamoto E., and Murakami Y. Effect of diabetes on vitamin B6 requirement in experimental animals. Diabetes Obes. Metab. 1 (1999) 221-225
34. Pertovaara A., Wei H., Kalmari J., and Ruotsalainen M. Pain behavior and response properties of spinal dorsal horn neurons following experimental diabetic neuropathy in the rat: modulation by nitecapone, a COMT inhibitor with antioxidant properties. Exp. Neurol. 167 (2001) 425-434
35. Pirart J., Lauvaux J.P., and Rey W. Blood sugar and diabetic complications. N. Engl. J. Med. 298 (1978) 1149
36. Pop-Busui R., Sima A., and Stevens M. Diabetic neuropathy and oxidative stress. Diabetes Metab. Res. Rev. 22 (2006) 257-273
37. Ramos K.M., Jiang Y., Svensson C.I., and Calcutt N.A. Pathogenesis of spinally mediated hyperalgesia in diabetes. Diabetes 56 (2007) 1569-1576
38. Rocha-Gonzalez H.I., Teran-Rosales F., Reyes-Garcia G., Medina-Santillan R., and Granados-Soto V. B vitamins increase the analgesic effect of diclofenac in the rat. Proc. West. Pharmacol. Soc. 47 (2004) 84-87
39. Sanchez-Ramirez G.M., Caram-Salas N.L., Rocha-Gonzalez H.I., Vidal-Cantu G.C., Medina-Santillan R., Reyes-Garcia G., and Granados-Soto V. Benfotiamine relieves inflammatory and neuropathic pain in rats. Eur. J. Pharmacol. 530 (2006) 48-53
40. Satoh J., Yagihashi S., and Toyota T. The possible role of tumor necrosis factor-alpha in diabetic polyneuropathy. Exp. Diabesity Res. 4 (2003) 65-71
41. Simeonov S., Pavlova M., Mitkov M., Mincheva L., and Troev D. Therapeutic efficacy of "Milgamma" in patients with painful diabetic neuropathy. Folia Med. (Plovdiv) 39 (1997) 5-10
42. Stracke H., Lindemann A., and Federlin K. A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy. Exp. Clin. Endocrinol. Diabetes 104 (1996) 311-316
43. Stracke H., Hammes H.P., Werkmann D., Mavrakis K., Bitsch I., Netzel M., Geyer J., Kopcke W., Sauerland C., Bretzel R.G., and Federlin K.F. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp. Clin. Endocrinol. Diabetes 109 (2001) 330-336
44. Stracke H., Gaus W., Achenbach U., Federlin K., and Bretzel R.G. Benfotiamine in Diabetic Polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. Exp. Clin. Endocrinol. Diabetes 116 (2008) 600-605
45. Sun Y., Lai M.S., and Lu C.J. Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials. Acta Neurol. Taiwan. 14 (2005) 48-54
46. Tang J., Wingerchuk D.M., Crum B.A., Rubin D.I., and Demaerschalk B.M. Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy. Neurologist 13 (2007) 164-167
47. Thornalley P.J. The potential role of thiamine (vitamin B(1)) in diabetic complications. Curr. Diabetes Rev. 1 (2005) 287-298
48. Thornalley P.J., Babaei-Jadidi R., Al Ali H., Rabbani N., Antonysunil A., Larkin J., Ahmed A., Rayman G., and Bodmer C.W. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 50 (2007) 2164-2170
49. Volvert M.L., Seyen S., Piette M., Evrard B., Gangolf M., Plumier J.C., and Bettendorff L. Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives. BMC Pharmacol. 8 (2008) 10
50. Wagner R., and Myers R.R. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport 7 (1996) 2897-2901
51. Wang Z.B., Gan Q., Rupert R.L., Zeng Y.M., and Song X.J. Thiamine, pyridoxine, cyanocobalamin and their combination inhibit thermal, but not mechanical hyperalgesia in rats with primary sensory neuron injury. Pain 114 (2005) 266-277
52. Williams H.L., Johnson D.J., McNeil J.S., and Wright D.G. Studies of cobalamin as a vehicle for the renal excretion of cyanide anion. J. Lab. Clin. Med. 116 (1990) 37-44
53. Winkler G., Pal B., Nagybeganyi E., Ory I., Porochnavec M., and Kempler P. Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy. Arzneimittelforschung 49 (1999) 220-224
54. Wu S., and Ren J. Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha. Neurosci. Lett. 394 (2006) 158-162
55. Zempleni J. Pharmacokinetics of vitamin B6 supplements in humans. J. Am. Coll. Nutr. 14 (1995) 579-586
56. Ziegler D. Treatment of diabetic neuropathy and neuropathic pain: how far have we come?. Diabetes Care 31 Suppl 2 (2008) S255-261
57. Ziegler D., and Gries F.A. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 46 Suppl 2 (1997) S62-66
58. Ziegler D., Nowak H., Kempler P., Vargha P., and Low P.A. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet. Med. 21 (2004) 114-121